People with metabolic diseases, such as metabolic syndrome, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (formerly NAFLD), [can also benefit from it] since ALCAR can support fatty acid metabolism, Warner adds
Davis Company
BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations
A thorough medical evaluation is crucial
Also in June, Novo Nordisk, the pharmaceutical company that makes Ozempic and Wegovy, filed multiple lawsuits against certain medical spas, weight loss and wellness clinics, and compounding pharmacies for "the unlawful marketing and sales of non-FDA approved counterfeit and compounded semaglutide products claiming to contain semaglutide," including allegations of false advertising, trademark infringement and unlawful sales of non FDA-approved compounded products
I reached out to a handful for comment but I have yet to receive a response
